Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO)

Historical Holders from Q3 2022 to Q3 2025

Symbol
SILO on Nasdaq
CUSIP
82711P201
Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
13.2M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
1.55M
Holdings value
$1.07M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
14
Number of buys
9
Number of sells
-7
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTRACOASTAL CAPITAL, LLC 9.99% 0% $1.04M $410K 1.38M +65.2% Mitchell P. Kopin Sep 30, 2025
Anson Funds Management LP 7.2% $714K 952K Anson Funds Management LP Sep 30, 2025
SEG Opportunity Fund, LLC 7.1% $619K 952K SEG Opportunity Fund, LLC Sep 29, 2025
RENAISSANCE TECHNOLOGIES LLC 0.84% -84.4% $38.3K -$193K 37.5K -83.5% Renaissance Technologies LLC Dec 31, 2024

Institutional Holders of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.55M $1.07M +$796K $0.69 14
2025 Q2 407K $256K +$89.1K $0.63 13
2025 Q1 248K $285K +$101K $1.17 12
2024 Q4 183K $162K -$141K $0.89 14
2024 Q3 338K $371K +$243K $1.10 12
2024 Q2 120K $118K +$5.46K $1.00 10
2024 Q1 113K $219K -$86.7K $1.95 10
2023 Q4 161K $231K +$79.3K $1.44 10
2023 Q3 106K $176K +$9.9K $1.67 8
2023 Q2 99.7K $204K +$25.7K $2.05 7
2023 Q1 87.2K $183K +$131K $2.10 6
2022 Q4 21.5K $72.3K -$187K $3.37 6
2022 Q3 50.7K $273K +$273K $5.41 3